Sasaki and colleagues reported that the incidence of colon tumors is suppressed in CCL3- or CCR5-deficient mice treated with AOM/DSS and coincides with lower accumulation of fibroblasts in dysplastic lesions compared with wild-type mice [28]. This evidence concerns the gene CCR5 and colonic neoplasm.